Protecting Life from Chemical Abortions Act
Latest action · Jan 27, 2023 Referred to the Subcommittee on Health.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedJan 17, 2023
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Protecting Life from Chemical Abortions Act
This bill nullifies certain changes made by the Food and Drug Administration (FDA) to dispensing requirements for mifepristone. (Mifepristone is a drug that is approved to end pregnancies through 10 weeks gestation when used in conjunction with the drug misoprostol. The procedure is often referred to as medication abortion or the abortion pill.)
The FDA regulates the use of mifepristone through the Mifepristone Risk Evaluation and Mitigation Strategy (REMS) program. The program requires health care providers to comply with certain requirements in order to prescribe or dispense mifepristone to end a pregnancy; the program previously included an in-person dispensing requirement that required mifepristone to be directly dispensed to patients in clinics, medical offices, or hospitals. During the COVID-19 public health emergency, the FDA temporarily stopped enforcing the in-person dispensing requirement, which allowed mail-order pharmacies to fill and dispense mifepristone prescriptions.
In January 2023, the FDA modified program requirements so as to (1) remove the in-person dispensing requirement, and (2) require pharmacies to be certified in the program in order to dispense mifepristone. The modifications allow retail pharmacies, after receiving certification, to dispense mifepristone pursuant to prescriptions that are written by program-certified prescribers.
The bill nullifies the January 2023 changes and prohibits the FDA from (1) exercising any enforcement discretion with respect to program requirements, or (2) reducing program protections until every state submits certain data regarding abortions to the Centers for Disease Control and Prevention.
The bill also generally prohibits the declaration of a public health emergency with respect to abortions.
Cosponsors 40
Members who signed on, in the order they did. Signatures ran from Jan 17, 2023 to Mar 29, 2024; 34 are original cosponsors, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-GA | Andrew S. Clyde | Original | Jan 17, 2023 |
| R-IA | Ashley Hinson | Original | Jan 17, 2023 |
| R-TX | August Pfluger | Original | Jan 17, 2023 |
| R-GA | Barry Loudermilk | Original | Jan 17, 2023 |
| R-VA | Ben Cline | Original | Jan 17, 2023 |
| R-MN | Brad Finstad | Original | Jan 17, 2023 |
| R-OH | Brad R. Wenstrup | Original | Jan 17, 2023 |
| R-TX | Brian Babin | Original | Jan 17, 2023 |
| R-FL | Brian J. Mast | Original | Jan 17, 2023 |
| R-FL | Daniel Webster | Original | Jan 17, 2023 |
| R-TN | Diana Harshbarger | Original | Jan 17, 2023 |
| R-CA | Doug LaMalfa | Original | Jan 17, 2023 |
| R-CO | Doug Lamborn | Original | Jan 17, 2023 |
| R-WI | Glenn Grothman | Original | Jan 17, 2023 |
| R-TX | Jake Ellzey | Original | Jan 17, 2023 |
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Jan 17, 2023 |
| Health Subcommittee | Referred Jan 27, 2023 |
Actions 3
Everything that happened, newest first.
- Jan 27, 2023Referred to the Subcommittee on Health.
- Jan 17, 2023Introduced in House
- Jan 17, 2023Referred to the House Committee on Energy and Commerce.
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 169, no. 12, January 17, 2023, page H244.
Printed hearings 1
Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.
| Number | Hearing | Committee | Held |
|---|---|---|---|
| Serial No. 118-48 | EXAMINING PROPOSALS THAT PROVIDE ACCESS TO CARE FOR PATIENTS AND SUPPORT RESEARCH FOR RARE DISEASES226 pages | Energy and Commerce Committee | Jun 14, 2023 |
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To prohibit the use or declaration of a public health emergency with respect to abortion, and for other purposes.
- Short Title(s) as Introduced
- Protecting Life from Chemical Abortions Act
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 1
Each version as it was printed, newest first.
- Jan 17, 2023Introduced in House
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.